.Pharmacolibrary.Drugs.N_NervousSystem.N02C_AntimigrainePreparations.N02CC02_Naratriptan.Naratriptan .Pharmacolibrary.Drugs.N_NervousSystem.N02C_AntimigrainePreparations.N02CC02_Naratriptan.Naratriptan| name: | Naratriptan | |
| ATC code: | N02CC02 | route: | oral |
| compartments: | 1 | |
| dosage: | 2.5 | mg |
| volume of distribution: | 170 | L |
| clearance: | 7.1 | L/h |
| other parameters in model implementation | ||
Naratriptan is a selective serotonin 5-HT1B/1D receptor agonist used for the acute treatment of migraine attacks with or without aura in adults. It is approved for use in several countries and is available as oral tablets.
Pharmacokinetic parameters reported for healthy adult volunteers following single oral dose administration.
Eiland, LS, & Hunt, MO (2010). The use of triptans for pediatric migraines. Paediatric drugs 12(6) 379–389. DOI:10.2165/11532860-000000000-00000 PUBMED:https://pubmed.ncbi.nlm.nih.gov/21028917
Jhee, SS, et al., & Cutler, NR (2001). Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review. Clinical pharmacokinetics 40(3) 189–205. DOI:10.2165/00003088-200140030-00004 PUBMED:https://pubmed.ncbi.nlm.nih.gov/11327198